Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Changing perceptions by measuring inputs and outputs?

Posted on May 12th, 2017 by in Pharma R&D

 

Perception is reality. I am sure everyone will have had an experience (or will do so shortly) where their perception of a situation is at odds with the perception of another. We all have our individual styles and preferences. Continue reading “Changing perceptions by measuring inputs and outputs?” »

Will 2017 be a Black Swan year?

Posted on February 6th, 2017 by in Pharma R&D

A few years ago, I sat with some friends aiming to make predictions for the year ahead. Our goal was to see how close we could get, with a plan to review the following new year. We made several predictions for the world of science Continue reading “Will 2017 be a Black Swan year?” »

New Developments in R&D

Posted on January 11th, 2017 by in Pharma R&D

There are some exciting changes happening at Rubius right now. We moved into a new lab,  and  more importantly, we’ve hired a new vice president of R&D, Tom Wickham. Continue reading “New Developments in R&D” »

Medicine Non-adherence: Time for a Personalized Healthcare Approach?

Posted on December 19th, 2016 by in Pharma R&D

It was interesting to note the article from Beth Snyder Bulik (1) that patient non-adherence to taking their prescribed medicines not only has a potential impact on their health and wellbeing, it also impacts the companies’ and healthcare providers’ bottom lines. Continue reading “Medicine Non-adherence: Time for a Personalized Healthcare Approach?” »

  1. 1
  2. 2
  3. 3